X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Genentech headquarters in South San Francisco. Photo: Jason Doiy/The Recorder

Sandoz International and its Switzerland-based subsidiary have been released from a patent infringement suit that aims to protect Genentech Inc.’s pulmonary fibrosis treatment from generic competition.

This premium content is locked for
Delaware Business Court Insider subscribers only.

*May exclude premium content
Already have an account?
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to groupsales@alm.com to learn more.

Tom McParland

Tom McParland of Delaware Law Weekly can be contacted at 215-557-2485 or at tmcparland@alm.com. Follow him on Twitter @TMcParlandTLI.

More from this author

On Trial: Lessons from a lifetime in the courtroomBook

Written by a distinguished N.Y. trial attorney, it distills the author's forty years of courtroom experience into a highly readable trove of wisdom and common-sense advice on the art of advocacy.
Get More Information

SuperConference 2019Event

SuperConference is the premier forum for informing, advancing and inspiring today?s General Counsel from Fortune 1000 Companies.
Get More Information

Banking Litigation & Regulation Forum 2019Event

Delivers key insights and practical solutions to address the complex minefield of the UK s banking litigation and regulatory field
Get More Information

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.